News
Summary A study led by Weill Cornell Medicine reveals that the APOE3-R136S mutation delays Alzheimer’s disease by inhibiting the cGAS-STING immune pathway. This mutation suppresses inflammation in ...
This rare mutation is found in the APOE gene encoding a cholesterol transport protein (apolipoprotein E), and was first discovered by a laboratory in Christchurch, New Zealand. In 2019, scientists ...
4 Bange E, et al. KEAP1 and TP53 frame genomic, evolutionary, and immunologic subtypes of lung adenocarcinoma with different sensitivity to immunotherapy. Journal of Thorac Oncol. 2021;16:2065-2077.
KEAP1, the other protein in the pathway, acts as a sensor for reactive oxygen species and controls the availability of NRF2 for cell protection. "We've studied NRF2 and KEAP1 for a long time, because ...
Immunogenomic correlates and clinical outcomes with PCP chemo-immunotherapy in patients with STK11- and/or KEAP1-mutant advanced nsNSCLC. Credit: Nature (2024). DOI: 10.1038/s41586-024-07943-7 ...
The POSEIDON exploratory analysis that dovetailed into the TRITON investigation saw STK11 mutations in 14% of the patients with nonsquamous NSCLC (n = 87), KEAP1 mutations in 6% (n = 51), and KRAS ...
Overview of effect of DRP-104 on KEAP1 mutant tumors and T cells. Credit: Science Advances (2024). DOI: 10.1126/sciadv.adm9859 ...
The KEAP1/Nrf2 pathway is also found in TKI-resistant cells in lung cancer. Krall et al. (2017) investigated the inhibitory effects of EGFR, ALK (anaplastic lymphoma kinase), BRAF, and MEK in lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results